Results 221 to 230 of about 22,784 (283)

(2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

, 2004
Dooseop Kim, Liping Wang, Maria Beconi, George J. Eiermann, Michael H. Fisher, Huaibing He, Gerard J. Hickey, Jennifer E. Kowalchick, Barbara Leiting, Kathryn A. Lyons, Frank Marsilio, Margaret E. McCann, Reshma A. Patel, Aleksandr Petrov, Giovanna Scapin, Sangita B. Patel, Ranabir Sinha Roy, Joseph K. Wu, Matthew J. Wyvratt, Bei B. Zhang, Lan Zhu, Nancy A. Thornberry, Ann E. Weber   +22 more
openalex   +1 more source

Periodontitis and GLP-1 pathways: a new frontier in oral-systemic health connections -a scoping review. [PDF]

Front Clin Diabetes Healthc
Jeong N, Chuang LH, Ho Y.
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists and Prior Major Adverse Limb Events in Patients With Diabetes.

JAMA Netw Open
Hsiao FC, Hsu TJ, Hsieh YJ, Tung YC, Chen DY, Lin CP, Chen SW, Chu PH.   +7 more
europepmc   +1 more source

The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice

, 2015
太輔 坂中
openalex   +1 more source

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptidyl Peptidase-IV Inhibitor, in Healthy Japanese Male Subjects: Rash Development in Men and Its Possible Mechanism

, 2013
Yutaka Takeuchi, Masayuki Namiki, Yasumi Kitahara, Setsuo Hasegawa, Akihiro Ohnishi, Nobuyuki Yasuda, Takashi Inoue, Richard J. Clark, Kazuto Yamazaki   +8 more
openalex   +2 more sources

Sodium-glucose cotransporter-2 inhibitors and the risk of all-cause mortality: a population-based cohort study using the UK Clinical Practice Research Datalink. [PDF]

Open Heart
Eroglu TE, Coronel R, Souverein PC.
europepmc   +1 more source

Rapid imaging of pulmonary metastasis from colorectal cancer with a red fluorescence probe targeting puromycin-sensitive aminopeptidase and dipeptidyl peptidase IV. [PDF]

Sci Rep
Kobayashi K, Fujita K, Kojima R, Hino R, Urano Y, Sato M.   +5 more
europepmc   +1 more source

Discovery of 2-[4-{{2-(2S,5R)-2-Cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic Acid (ABT-279):  A Very Potent, Selective, Effective, and Well-Tolerated Inhibitor of Dipeptidyl Peptidase-IV, Useful for the Treatment of Diabetes

, 2006
David J. Madar, Hana Kopecka, Daisy Pireh, Hong Yong, Zhonghua Pei, Xiaofeng Li, Paul E. Wiedeman, Stevan W. Djurić, Thomas W von Geldern, Michael G. Fickes, Lakshmi Bhagavatula, Todd S. McDermott, Steven J. Wittenberger, Steven J. Richards, Kenton L. Longenecker, Kent D. Stewart, Thomas Lübben, Stephen J. Ballaron, Michael A. Stashko, Michelle A. Long, Heidi Wells, Bradley A. Zinker, Amanda K. Mika, David W. A. Beno, Anita J. Kempf-Grote, James S. Polakowski, Jason A. Segreti, Glenn A. Reinhart, Ryan M. Fryer, Hing L. Sham, James M. Trevillyan   +30 more
openalex   +1 more source

Genetic variants associated with glycemic and weight loss response to vildagliptin as add-on therapy to metformin in Egyptian obese type 2 diabetic patients: potential consequences on cardiac risk factors. [PDF]

Eur J Med Res
Saber K, Ismail R, Bassyouni A, El-Shafee M, Hassan MH.   +4 more
europepmc   +1 more source

Discovery and characterization of novel bioactive peptides from marine secondary products [PDF]

, 2014
Falkenberg, Susan Skanderup
core